1. Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt am Main, Germany
2. Department of Immunotechnology, Lund University, Lund, Sweden
3. Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Preclinical Pharmacology and In-Vitro Toxicology, Hannover, Germany
4. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany
5. Dynamic42 GmbH, Jena, Germany
6. Translational Medicine, Novartis Institutes of Biomedical Research, Basel, Switzerland
7. Chemical and Preclinical Safety, Merck Healthcare KGaA, Darmstadt, Germany
8. EpiEndo Pharmaceuticals ehf, Reykjavík, Iceland